Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic …
PM Ellis, N Coakley, R Feld, S Kuruvilla, YC Ung - Current oncology, 2015 - mdpi.com
Introduction: This systematic review addresses the use of epidermal growth factor receptor
(egfr) inhibitors in three populations of advanced non-small-cell lung cancer (nsclc) patients …
(egfr) inhibitors in three populations of advanced non-small-cell lung cancer (nsclc) patients …
[PDF][PDF] Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a …
PM Ellis, N Coakley, R Feld, S Kuruvilla, YC Ung - Current Oncology, 2015 - Citeseer
Introduction This systematic review addresses the use of epidermal growth factor receptor
(egfr) inhibitors in three populations of advanced non-small-cell lung cancer (nsclc) patients …
(egfr) inhibitors in three populations of advanced non-small-cell lung cancer (nsclc) patients …
Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic …
PM Ellis, N Coakley, R Feld, S Kuruvilla… - Current …, 2015 - search.ebscohost.com
Introduction This systematic review addresses the use of epidermal growth factor receptor
(EGFR) inhibitors in three populations of advanced non-small-cell lung cancer (NSCLC) …
(EGFR) inhibitors in three populations of advanced non-small-cell lung cancer (NSCLC) …
Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic …
PM Ellis, N Coakley, R Feld, S Kuruvilla… - … Oncology (Toronto, Ont …, 2015 - europepmc.org
Methods Ninety-six randomized controlled trials found using the medline and embase
databases form the basis of this review. Results In the first-line setting, data about the …
databases form the basis of this review. Results In the first-line setting, data about the …
[HTML][HTML] Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a …
PM Ellis, N Coakley, R Feld, S Kuruvilla… - Current …, 2015 - ncbi.nlm.nih.gov
Methods Ninety-six randomized controlled trials found using the medline and embase
databases form the basis of this review. Results In the first-line setting, data about the …
databases form the basis of this review. Results In the first-line setting, data about the …
Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic …
PM Ellis, N Coakley, R Feld… - Current oncology …, 2015 - pubmed.ncbi.nlm.nih.gov
Introduction This systematic review addresses the use of epidermal growth factor receptor
(egfr) inhibitors in three populations of advanced non-small-cell lung cancer (nsclc) patients …
(egfr) inhibitors in three populations of advanced non-small-cell lung cancer (nsclc) patients …
[PDF][PDF] Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a …
PM Ellis, N Coakley, R Feld, S Kuruvilla… - Current …, 2015 - pdfs.semanticscholar.org
Introduction This systematic review addresses the use of epidermal growth factor receptor
(egfr) inhibitors in three populations of advanced non-small-cell lung cancer (nsclc) patients …
(egfr) inhibitors in three populations of advanced non-small-cell lung cancer (nsclc) patients …
Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib, Erlotinib, Afatinib, Dacomitinib, and Icotinib in the Treatment of Non-Small-Cell Lung Cancer: A …
PM Ellis, N Coakley, R Feld, S Kuruvilla, YC Ung - Current Oncology, 2015 - cir.nii.ac.jp
抄録< jats: p> Introduction: This systematic review addresses the use of epidermal growth
factor receptor (egfr) inhibitors in three populations of advanced non-small-cell lung cancer …
factor receptor (egfr) inhibitors in three populations of advanced non-small-cell lung cancer …
Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic …
PM Ellis, N Coakley, R Feld, S Kuruvilla… - … Oncology (Toronto, Ont …, 2015 - europepmc.org
Methods Ninety-six randomized controlled trials found using the medline and embase
databases form the basis of this review. Results In the first-line setting, data about the …
databases form the basis of this review. Results In the first-line setting, data about the …
Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic …
PM Ellis, N Coakley, R Feld, S Kuruvilla… - Current …, 2015 - search.ebscohost.com
Introduction This systematic review addresses the use of epidermal growth factor receptor
(EGFR) inhibitors in three populations of advanced non-small-cell lung cancer (NSCLC) …
(EGFR) inhibitors in three populations of advanced non-small-cell lung cancer (NSCLC) …